173-183
Expression and clinical significance of pattern recognition receptor-associated genes in hand, foot and mouth disease
Authors: Muqi Wang, Huiling Deng, Yuan Chen, Yikai Wang, Yufeng Zhang, Chenrui Liu, Meng Zhang, Ting Li, Shuangsuo Dang, Yaping Li
Number of views: 1
Objective: To explore which pattern recognition receptors (PRRs)
play a key role in the development of hand, foot, and mouth disease
(HFMD) by analyzing PRR-associated genes.
Methods: We conducted a comparative analysis of PRR-associated
gene expression in human peripheral blood mononuclear cells
(PBMCs) infected with enterovirus 71 (EV-A71) which were
derived from patients with HFMD of different severities and at
different stages. A total of 30 PRR-associated genes were identified
as significantly upregulated both over time and across different
EV-A71 isolates. Subsequently, ELISA was employed to quantify
the expression of the six most prominent genes among these 30
identified genes, specifically, BST2, IRF7, IFI16, TRIM21, MX1, and
DDX58.
Results: Compared with those at the recovery stage, the expression
levels of BST2 (P=0.027), IFI16 (P=0.016), MX1 (P=0.046) and
DDX58 (P=0.008) in the acute stage of infection were significantly
upregulated, while no significant difference in the expression levels
of IRF7 (P=0.495) and TRIM21 (P=0.071) was found between
different stages of the disease. The expression levels of BST2, IRF7,
IFI16 and MX1 were significantly higher in children infected with
single pathogen than those infected with mixed pathogens, and
BST2, IRF7, IFI16 and MX1 expression levels were significantly
lower in coxsackie B virus (COXB) positive patients than the
negative patients. Expression levels of one or more of BST2, IRF7,
IFI16, TRIM21, MX1 and DDX58 genes were correlated with PCT
levels, various white blood cell counts, and serum antibody levels
that reflect disease course of HFMD. Aspartate aminotransferase
was correlated with BST2, MX1 and DDX58 expression levels.
Conclusions: PRR-associated genes likely initiate the immune
response in patients at the acute stage of HFMD.